ESMO FAMILY SITES
Welcome to the European Society for Medical Oncology (ESMO), the leading European professional organization representing medical oncologists. more about ESMO ...
ESMO NEWS
- 04.02.10 - Today, 4 February, marks World Cancer Day!
Support the cancer prevention campaign and sign the World Cancer Declaration now
- 27.01.10 - Applications open online until 26 February 2010 for ACORD 2010 – the Australia & Asia Pacific Clinical Oncology Research Development Workshop
12-17 September 2010 on the Sunshine Coast, Australia
- 19.01.10 - 4 February marks World Cancer Day!
Join ESMO in its support of UICC-led and WHO-supported World Cancer Day 2010 and spread the word...
- 11.01.10 - ESMO as official partner with ECCO, AACR, and EORTC for 12th ‘Flims’ Workshop on Methods in Clinical Cancer Research, 19-25 June 2010, Flims, Switzerland
Junior physicians submit your application online before 12 February 2010 to participate in this...
- 11.01.10 - Participate in or publicize the nutritionDay worldwide project on 21 January 2010
Obtain statistics on how your institute rates regarding nutrition and patient outcome
[more...]
ONCOLOGY NEWS
- 04.02.10 - Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma
Nonnodal presentation, predominantly hypermutated IGVH, lack of genomic complexity, and absence of...
- 02.02.10 - Why biopsying metastatic breast cancer should be routine?
Therapeutic decisions in this setting are based on the features of the tumor at initial diagnosis
- 29.01.10 - Large study confirms that positive peritoneal cytology predicts poor disease-specific survival for patients with gastric cancer
Although long-term survival in patients with positive peritoneal cytology is extremely uncommon,...
- 27.01.10 - Integrins as targets for cancer therapy
Biological implications and therapeutic opportunities
- 26.01.10 - The European Medicines Agency grants a conditional marketing authorisation for ofatumumab for the treatment of patients with chronic lymphocytic leukaemia who are refractory to fludarabine and alemtuzumab
Meeting highlights from the Committee for Medicinal Products for Human Use, 18-21 January 2010
[more...]
myESMO Network
ESMO Practice Tools
Virtual Meetings
ESMO Fellowship Program